Filtry
Wyświetlone 1-2 z 2 rekordów.
The effect of potassium canrenoate (mineralocorticoid receptor antagonist) on the markers of inflammation in the treatment of COVID-19 pneumonia and fibrosis : a secondary analysis of randomized placebo-controlled clinical trial
Karolak Igor
International Journal of Molecular Sciences, 2023, vol. 24 iss. 18, [br. s.], 14247
Kategoria Publikacje pracowników US
Udostępniono 6 gru 2023
Mineralocorticoid receptor antagonist (potassium canrenoate) does not influence outcome in the treatment of COVID-19-associated pneumonia and fibrosis—a randomized placebo controlled clinical trial
Kotfis Katarzyna
Pharmaceuticals, 2022, vol. 15 iss. 2, [br. s.], 200
Kategoria Publikacje pracowników US
Udostępniono 10 mar 2022